Versuchen GOLD - Frei

THE HIDDEN RISKS OF AMERICA'S MOST POPULAR PRESCRIPTION PAINKILLER

Mint New Delhi

|

December 26, 2025

Gabapentin has soared in popularity as an alternative to opioids, but patients are finding it can cause harm

- Betsy McKay & Shalini Ramachandran

THE HIDDEN RISKS OF AMERICA'S MOST POPULAR PRESCRIPTION PAINKILLER

While the medical establishment has mostly maintained that gabapentin isn't habit-forming, some patients have reported debilitating adverse effects when they try to taper off it.

(ISTOCKPHOTO)

John Avery was just back from a guys’ golfing weekend and doing dead lifts at the gym in 2023 when he felt a pop in his lower back. A disc had slipped and was pressing on a nerve.

After months of rest, physical therapy and steroids, he was prescribed a drug called gabapentin by a pain management specialist who told Avery that it could help calm his nerve pain and that it was “nonaddictive,” Avery recalled. He took the medicine for a few days, then had surgery, and took it again for a little more than three weeks.

The 33-year-old former high-school physical education teacher in Newark, Ill., said he experienced a severe protracted withdrawal when he stopped, which led to neurological symptoms now that make his original back problem seem like “a paper cut” by comparison.

His symptoms include shaking and a burning sensation throughout his body, muscle spasms and a racing pulse. He can’t sleep for more than a half-hour at a time, and has lost so much weight that his wife said his calves are the size of her arms.

The change in his life, he said, is “beyond dramatic.”

Approved by the Food and Drug Administration decades ago for seizures and nerve pain from shingles, gabapentin is now the seventh-most widely prescribed drug in the U.S., according to the Iqvia Institute for Human Data Science. About 15.5 million people were prescribed gabapentin in 2024, according to an analysis by Centers for Disease Control and Prevention researchers.

Studies show that most of the prescriptions are written to treat conditions that it wasn't approved for—a practice that is legal and common, but means the FDA hasn't vetted its risks and benefits for those purposes.

WEITERE GESCHICHTEN VON Mint New Delhi

Mint New Delhi

The names we carry

A nickname isn't just what someone calls you. It's how they see you, and how you learn to see yourself around them

time to read

2 mins

January 10, 2026

Mint New Delhi

Mint New Delhi

A walk inside the archives of Tarun Tahiliani

The glass room, filled with swatches and garments, holds the key to the past, present and future of the 30-year-old brand

time to read

4 mins

January 10, 2026

Mint New Delhi

Reliance Jio plans mega IPO with a 2.5% float

Reliance Jio Platforms is considering an initial public offering this year that would float 2.5% of the company, people familiar with the matter said, a move that could make it India’s largest-ever IPO worth over $4 billion.

time to read

1 min

January 10, 2026

Mint New Delhi

US trade fears rattle markets; Nifty below 26,000

Domestic equities were shaken by the ‘Trump factor’ throughout the week, leaving India the worst-performing major market globally as risk-off sentiment gripped investors.

time to read

1 mins

January 10, 2026

Mint New Delhi

Mint New Delhi

‘Dream is to be a one-stop shop for child and mother’

Alia Bhatt and Reliance Retail-backed Ed-A-Mamma has ventured into the kids and baby personal care category, with plans to tap other segments, such as teenage clothing and pet care, the actor-entrepreneur told *Mint* in an interview on Friday.

time to read

1 mins

January 10, 2026

Mint New Delhi

Mint New Delhi

Drawing on faith and supernatural forces

Amitav Ghosh's latest novel is a page turner, often veering into a realm of magical occurrences, but stretches the reader's beliefs a bit too far

time to read

5 mins

January 10, 2026

Mint New Delhi

A city festival displays the power of shared spaces

The 10-day BLR Hubba, which begins on 16 January, will have 250 events in more than 20 venues in Bengaluru

time to read

4 mins

January 10, 2026

Mint New Delhi

Mint New Delhi

Sebi for sweeping clean-up of margin and trading norms

Regulator proposes ₹5 crore net-worth for MTF brokers.

time to read

1 mins

January 10, 2026

Mint New Delhi

Mint New Delhi

The world's best bear turns 100

In its centenary year, A.A. Milne's beloved teddy bear, Winnie the Pooh, can teach adults a lesson or two in humility

time to read

5 mins

January 10, 2026

Mint New Delhi

Mint New Delhi

Federal Bank unveils Fortuna Wave to appeal to all young, mobile-first clients

Federal Bank's new brand identity, anchored by a refreshed logo called Fortuna Wave, comes at a moment when legacy banks are being forced to rethink how they appear, speak and scale—not because the old has failed, but because the audience has shifted.

time to read

3 mins

January 10, 2026

Listen

Translate

Share

-
+

Change font size